GHO Capital Appoints Jim Datin, former President and CEO of BioAgilityx, as Operating Partner

Posted: 21 Feb 2023
  • Former GHO portfolio CEO to support further growth acceleration, geographic expansion and value creation across its portfolio

London, UK – Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, today announces the appointment of Jim Datin as Operating Partner.

Bringing more than 30 years of experience in the pharmaceutical and life sciences industry, Jim is a seasoned executive having held senior leadership roles in companies across the United States, Canada, Europe, and Asia. Most recently, Jim served as President and Chief Executive Officer of BioAgilytix, a Contract Research Lab (“CRL”), and former GHO portfolio company. He has completed more than 40 transactions across venture and buyout, including a number of mergers & acquisitions and IPOs.

During Jim’s tenure and alongside GHO, BioAgilytix executed three transformational add-on acquisitions, expanding geographic footprint across the US and establishing an APAC presence, positioning the business as a leader in analytical testing for biologics drug development. BioAgilytix was recognised by the Inc. 5000 list of Fastest Growing Companies for seven years consecutively. Jim is currently a board member of GHO portfolio companies Alcami Corporation and Sapio Sciences, as well the North Carolina Biotechnology Center and OraSure Technologies.

In his new role, Jim will leverage his extensive industry experience to support GHO through deal origination across Europe and the US, whilst also supporting value creation within the GHO portfolio.

The Partners at GHO Capital commented: “GHO fosters progress in the sector by supporting the individuals driving the next generation of healthcare. As CEO of BioAgilytix, Jim was one of those individuals and he has been an invaluable source of knowledge and expertise to GHO, both as a portfolio company leader and as a close friend of the firm over many years. As an Operating Partner, our portfolio will benefit from Jim’s extensive knowledge base to support in generating long-term sustainable value.”

I am passionate about supporting the next generation of ambitious management teams in the healthcare sector. I am delighted to be joining forces again with the team at GHO, working with them to identify new opportunities for growth and value creation – building industry leading, innovative and high growth businesses.
Jim Datin
Operating Partner at GHO Capital